Healthcare provider profile · identity verified

Ram S Garg, MD

Neurology · TAYLOR, MI · NPI 1164402442

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	800	118
Topiramate	Topiramate	478	122
Gabapentin	Gabapentin	457	93
Ibuprofen	Ibuprofen	405	87
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	334	49
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	278	60
Levetiracetam	Levetiracetam	274	48
Amitriptyline Hcl	Amitriptyline Hcl	269	70
Primidone	Primidone	257	67
Ropinirole Hcl	Ropinirole Hcl	248	60
Memantine Hcl	Memantine Hcl	220	54
Pregabalin	Pregabalin	205	43
Lamotrigine	Lamotrigine	199	39
Omeprazole	Omeprazole	199	57
Lacosamide	Lacosamide	174	26
Sumatriptan Succinate	Sumatriptan Succinate	168	41
Meclizine Hcl	Meclizine Hcl	158	62
Atorvastatin Calcium	Atorvastatin Calcium	153	52
Albuterol Sulfate Hfa	Albuterol Sulfate	146	37
Lisinopril	Lisinopril	143	40
Amlodipine Besylate	Amlodipine Besylate	142	47
Baclofen	Baclofen	134	25
Briviact	Brivaracetam	124	20
Pantoprazole Sodium	Pantoprazole Sodium	123	35
Meloxicam	Meloxicam	119	44
Quetiapine Fumarate	Quetiapine Fumarate	118	25
Duloxetine Hcl	Duloxetine Hcl	115	26
Acetaminophen-Codeine	Acetaminophen With Codeine	114	21
Alprazolam	Alprazolam	114	18
Tramadol Hcl	Tramadol Hcl	111	24
Levothyroxine Sodium	Levothyroxine Sodium	110	27
Trazodone Hcl	Trazodone Hcl	108	23
Divalproex Sodium Er	Divalproex Sodium	104	28
Escitalopram Oxalate	Escitalopram Oxalate	90	20
Propranolol Hcl	Propranolol Hcl	90	26
Carbamazepine	Carbamazepine	87	19
Metformin Hcl	Metformin Hcl	86	21
Celecoxib	Celecoxib	82	15
Clonazepam	Clonazepam	76	14
Donepezil Hcl	Donepezil Hcl	74	20
Lorazepam	Lorazepam	73	12
Phenobarbital	Phenobarbital	73	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	72	19
Lidocaine	Lidocaine	70	18
Fycompa	Perampanel	69	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	66	13
Mirtazapine	Mirtazapine	65	23
Aptiom	Eslicarbazepine Acetate	62	suppressed
Clonidine Hcl	Clonidine Hcl	59	suppressed
Tizanidine Hcl	Tizanidine Hcl	58	17
Diclofenac Sodium	Diclofenac Sodium	55	20
Oxcarbazepine	Oxcarbazepine	55	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	53	17
Fluticasone Propionate	Fluticasone Propionate	52	12
Aripiprazole	Aripiprazole	49	suppressed
Losartan Potassium	Losartan Potassium	49	17
Oxybutynin Chloride	Oxybutynin Chloride	46	16
Naproxen Sodium	Naproxen Sodium	45	suppressed
Trintellix	Vortioxetine Hydrobromide	45	suppressed
Oxycodone Hcl	Oxycodone Hcl	44	suppressed
Sertraline Hcl	Sertraline Hcl	44	12
Valtoco	Diazepam	44	13
Carbamazepine Er	Carbamazepine	43	suppressed
Methocarbamol	Methocarbamol	43	15
Prednisone	Prednisone	43	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	42	11
Rexulti	Brexpiprazole	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	11
Eliquis	Apixaban	40	13
Famotidine	Famotidine	38	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	38	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Austedo	Deutetrabenazine	37	suppressed
Carvedilol	Carvedilol	37	suppressed
Temazepam	Temazepam	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Naproxen	Naproxen	35	15
Diazepam	Diazepam	33	suppressed
Divalproex Sodium	Divalproex Sodium	33	suppressed
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Bumetanide	Bumetanide	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	14
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Metoprolol Succinate	Metoprolol Succinate	31	suppressed
Torsemide	Torsemide	31	suppressed
Tysabri	Natalizumab	30	suppressed
Betaseron	Interferon Beta-1b	28	suppressed
Furosemide	Furosemide	28	suppressed
Epidiolex	Cannabidiol (Cbd)	27	suppressed
Nayzilam	Midazolam	27	11
Zonisamide	Zonisamide	27	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	26	suppressed
Lamotrigine Er	Lamotrigine	26	suppressed
Amantadine	Amantadine Hcl	25	suppressed
Kesimpta Pen	Ofatumumab	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Atenolol	Atenolol	23	suppressed
Dalfampridine Er	Dalfampridine	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Topiramate Er	Topiramate	22	suppressed
Ubrelvy	Ubrogepant	22	suppressed
Aimovig Autoinjector	Erenumab-Aooe	21	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Benztropine Mesylate	Benztropine Mesylate	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Fingolimod	Fingolimod Hcl	19	suppressed
Linzess	Linaclotide	19	suppressed
Ongentys	Opicapone	19	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Clobazam	Clobazam	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Vimpat	Lacosamide	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Carisoprodol	Carisoprodol	17	suppressed
Qulipta	Atogepant	17	suppressed
Ibu	Ibuprofen	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Halobetasol Propionate	Halobetasol Propionate	15	suppressed
Megestrol Acetate	Megestrol Acetate	15	suppressed
Risperidone	Risperidone	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Dilantin	Phenytoin Sodium Extended	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Prednisolone Acetate	Prednisolone Acetate	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Rufinamide	Rufinamide	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Xcopri	Cenobamate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nurtec Odt	Rimegepant Sulfate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Selegiline Hcl	Selegiline Hcl	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Avonex (4 Pack)	Interferon Beta-1a	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Estradiol	Estradiol	12	suppressed
Neupro	Rotigotine	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nystatin	Nystatin	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Teriflunomide	Teriflunomide	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Glipizide	Glipizide	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Vraylar	Cariprazine Hcl	11	suppressed
Vumerity	Diroximel Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error